We are live on
!
Find out more
SC
Searle & Co Portfolio holdings
AUM
$398M
1-Year Est. Return
22.87%
This Fund
S&P 500
This Quarter
Est. Return
+1.4%
1 Year Est. Return
+22.87%
3 Year Est. Return
+66.45%
5 Year Est. Return
+103%
10 Year Est. Return
+295.26%
AUM
$427M
AUM Growth
+$34.6M
(+8.8%)
Cap. Flow
+$33M
Cap. Flow
% of AUM
7.75%
Top 10 Holdings %
Top 10 Hldgs %
42.72%
Holding
188
New
25
Increased
60
Reduced
24
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$3.71M |
| 2 |
Apple
AAPL
|
+$3.22M |
| 3 |
Amgen
AMGN
|
+$2.12M |
| 4 |
Eli Lilly
LLY
|
+$2M |
| 5 |
Texas Instruments
TXN
|
+$1.82M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baxter International
BAX
|
+$1.36M |
| 2 |
Nike
NKE
|
+$865K |
| 3 |
Incyte
INCY
|
+$413K |
| 4 |
Bank of America
BAC
|
+$337K |
| 5 |
Heron Therapeutics
HRTX
|
+$231K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 23.49% |
| 2 | Technology | 18.61% |
| 3 | Healthcare | 13.85% |
| 4 | Industrials | 10.48% |
| 5 | Consumer Staples | 9.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Lowe's Companies
LOW
$115B
| $272K | 0.06% |
1,232
| – | – |
|
152
Constellation Brands
STZ
$22.9B
| $270K | 0.06% |
1,050
| – | – |
|
153
Newmont
NEM
$95.2B
| $269K | 0.06% |
+6,427
| New | +$263K |
|
154
Trane Technologies
TT
$103B
| $263K | 0.06% |
800
| – | – |
|
155
TechnipFMC
FTI
$28.7B
| $262K | 0.06% |
+10,000
| New | +$258K |
|
156
Paychex
PAYX
$41B
| $261K | 0.06% |
2,200
| – | – |
|
157
Lockheed Martin
LMT
$117B
| $257K | 0.06% |
550
| – | – |
|
158
Accenture
ACN
$88.6B
| $256K | 0.06% |
844
+41
| +5% | +$12.6K |
|
159
General Mills
GIS
$20.1B
| $253K | 0.06% |
4,000
| – | – |
|
160
Veralto
VLTO
$22.9B
| $249K | 0.06% |
2,612
-179
| -6% | -$17.1K |
|
161
iShares Global Tech ETF
IXN
$8.7B
| $248K | 0.06% |
3,000
| – | – |
|
162
Blackstone
BX
$151B
| $248K | 0.06% |
2,000
| – | – |
|
163
Vanguard Mid-Cap ETF
VO
$105B
| $242K | 0.06% |
4,000
| – | – |
|
164
Adobe
ADBE
$93.3B
| $236K | 0.06% |
424
-33
| -7% | -$16K |
|
165
Constellation Energy
CEG
$90.5B
| $231K | 0.05% |
1,155
| – | – |
|
166
Public Storage
PSA
$55.4B
| $230K | 0.05% |
+800
| New | +$221K |
|
167
MPLX
MPLX
$58B
| $230K | 0.05% |
5,400
| – | – |
|
168
SPDR Gold Trust
GLD
$129B
| $225K | 0.05% |
1,046
| – | – |
|
169
Zimmer Biomet
ZBH
$17.4B
| $217K | 0.05% |
2,000
| – | – |
|
170
Netflix
NFLX
$285B
| $216K | 0.05% |
+3,200
| New | +$200K |
|
171
Brookfield Asset Management
BAM
$75.6B
| $216K | 0.05% |
5,662
| – | – |
|
172
State Street SPDR S&P Metals & Mining ETF
XME
$3.89B
| $215K | 0.05% |
+3,620
| New | +$222K |
|
173
HP
HPQ
$22.1B
| $211K | 0.05% |
+6,022
| New | +$191K |
|
174
Ascendis Pharma A/S
ASND
$16.5B
| $205K | 0.05% |
+1,500
| New | +$204K |
|
175
Novartis
NVS
$285B
| $202K | 0.05% |
+1,900
| New | +$191K |
|
Similar funds
CF
VC
DL
ECA
BWM
MHC
LSA
THL
Searle & Co's Q2 2024 Portfolio in Review
As of Q2 2024, Searle & Co held 188 positions worth $427M, up 8.8% from $392M the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Searle & Co deployed $33M of net new capital in Q2 2024, opening 25 new positions and adding to 60 existing holdings. Its largest new stake was Amgen: 7,221 shares worth $2.26M.
By sector, the portfolio is most concentrated in Financials at 23% of assets, down from 24% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Nike, an estimated $865K trimmed.
- Searle & Co's largest Q2 2024 buy was Amgen: 7,221 shares worth $2.26M.
- Searle & Co added most to JPMorgan Chase in Q2 2024, an estimated $3.71M increase.
- Searle & Co's biggest Q2 2024 reduction was Nike, cutting an estimated $865K.
- Searle & Co fully exited Baxter International in Q2 2024, selling an estimated $1.36M.
- Searle & Co's ten largest holdings make up 43% of its $427M portfolio in Q2 2024.
- Searle & Co opened 25 new positions and closed 4 in Q2 2024.
- Searle & Co's portfolio value rose 8.8% quarter-over-quarter to $427M.
Based on Searle & Co's 13F filing for Q2 2024, filed 30 Jul 2024.